Journal of Pharmaceutical Research International最新文献

筛选
英文 中文
Advancement in Diagnostic Aids for Oral Premalignant Lesions 口腔癌前病变诊断辅助工具的研究进展
Journal of Pharmaceutical Research International Pub Date : 2023-09-19 DOI: 10.9734/jpri/2023/v35i257429
Baraa Issam Abdulrahman
{"title":"Advancement in Diagnostic Aids for Oral Premalignant Lesions","authors":"Baraa Issam Abdulrahman","doi":"10.9734/jpri/2023/v35i257429","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i257429","url":null,"abstract":"Introduction: Precancerous lesions, conditions, and early-stage oral cancer cannot be sufficiently identified solely through visual inspection and may be prone to be inadvertently disregarded. Distinguishing between early-stage cancer, precancerous lesions, and benign tumors can pose a challenge due to the striking resemblance in their visual characteristics. Using surgical biopsy as a diagnostic modality is widely regarded as the gold standard in the medical community. However, it is essential to acknowledge that acquiring professional services for this procedure can prove impractical in certain circumstances. Hence this paper presents a concise review of a wide range of advanced diagnostic aids employed in detection of Oral Premalignant Lesions (OPL).
 Methods: The literature search utilized appropriate keywords to search online databases like PubMed, Medline, Google Scholar, EBSCO, Wiley science library, and Saudi digital library.
 Results: Alternative screening methods that are noninvasive, readily executed, and exhibit a high degree of accuracy are the established criteria for considering a test as a viable substitute for histopathology. Early diagnosis is a paramount factor in the effective management of oral cancer. Vital staining, immunocytochemistry, fluorescence imaging, laser confocal microscopy, Raman spectroscopy, and Fourier transform infrared spectroscopy diagnostic modalities are employed for the timely identification of oral premalignant lesions.
 Conclusion: Recent advances have improved the diagnostic aids in easy and accurate detection of oral premalignant lesions thereby facilitating effective management and mitigation strategies at an early stage of the lesion.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":"198 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135014206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-anaemic and Anti-leukopenic Effects of Hydromethanolic Extracts of Tiger Nut and Ginger on Alloxan- induced Diabetic Rats 虎坚果和生姜氢甲醇提取物对四氧嘧啶诱导的糖尿病大鼠的抗贫血和抗白细胞减少作用
Journal of Pharmaceutical Research International Pub Date : 2023-09-18 DOI: 10.9734/jpri/2023/v35i257428
Samuel C. Iwuji, Kosisochukwu A. Uzokwe, Francis O. Nwokorie, Wilson C. Okafor, Sixtus A. Okafor
{"title":"Anti-anaemic and Anti-leukopenic Effects of Hydromethanolic Extracts of Tiger Nut and Ginger on Alloxan- induced Diabetic Rats","authors":"Samuel C. Iwuji, Kosisochukwu A. Uzokwe, Francis O. Nwokorie, Wilson C. Okafor, Sixtus A. Okafor","doi":"10.9734/jpri/2023/v35i257428","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i257428","url":null,"abstract":"Aims: This study investigated the anti-anaemic and anti- leukopenic effects of hydromethanolic (1:4) extracts of Cyperus esculentus (Tiger nut) and Zingiber officinale (Ginger) on the alloxan- induced diabetic albino rats.
 Place: The in vivo study took place in the Department of Biochemistry, Micheal Okpara University of Agriculture Umudike, Abia state.
 Methods: Fresh Cyperus esculentus and Zingiber officinale was air dried at room temperature, grounded into fine powder and extracted with hydromethanol in ratio of 20:80 using Soxhlet extraction method. The albino rats (total number of 36) were randomly divided into 6 groups of 6 rats each: Group 1 (Normal control); Group 2 (Diabetic); Group 3 (Glibenclamide); Group 4 (500mg/dl Cyperus esculentus); Group 5 (500mg/dl Zingiber officinale) and Group 6 (250mg/dl Cyperus esculentus + 250 mg/dl Zingiber officinale, 50:50) were administered orally. Group 2 to 6 were administered with 160mg/kg alloxan monohydrate intraperitoneally to induce a diabetic state. The haematological parameters determined were PCV, HB, RBC, TWBC, MCV, MCH and MCHC.
 Results: The diabetic group treated with the Glibenclamide and 500 mg/kg Zingiber officinale extract had significant recovery (compared with the normal control) from the diabetic- induced depletion of Hb, PCV and RBC than the diabetic group treated with 250 mg/kg Cyperus esculentus + 250 mg/kg Zingiber officinale extracts. 500 mg/kg Cyperus esculentus extract showed the least recovery from diabetic induced anaemia.
 Conclusion: Ginger extract showed value in the recovery from anaemia and leucopenia associated with diabetes having significantly improved the values of RBC, PCV, haemoglobin and TWBC in the diabetic rats more than the effects of Tigernut and combined (ginger and tigernut) extracts. Ginger extract treatment might also increase the defense mechanism of the body against infections in diabetes.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135153718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine and Adjuvant Mediated Autoimmunity 疫苗和佐剂介导的自身免疫
Journal of Pharmaceutical Research International Pub Date : 2023-09-14 DOI: 10.9734/jpri/2023/v35i247426
Ibrahim M. S. Shnawa
{"title":"Vaccine and Adjuvant Mediated Autoimmunity","authors":"Ibrahim M. S. Shnawa","doi":"10.9734/jpri/2023/v35i247426","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i247426","url":null,"abstract":"The macrophage, natural killer cells, B and T cells are the outstanding formed elements of human immune system. In normal immune homeostatic state these cells in a way or other recognize the host body components as self via the immune surveillance mechanisms. Though when there was a shift in immune homeostasis due to chronic induction by; i - environmental stimulus, ii –interplay of predisposing genetic elements, iii-family history, iv – bystander pathologic inflammatory system .Immune cells becomes prone to recognize the impart self or self as a non-self with subsequent induction of autoimmune diseases. The present opinion paper was aimed at vaccine and adjuvant mediated autoimmune diseases. Timelines for vaccine and adjuvant induced autoimmunity were made. Different human approved vaccines induce different autoimmune disease, more than on vaccine may induce same autoimmune disease. Shoenfeld Syndrome, the adjuvant induce autoimmune/ inflammatory syndrome. Under the umbrella of this syndrome five conditions grouped as; i – Postvaccination with an adjuvanated vaccine, ii – macrophagic myofasciitis, iii – sick building disease condition iv – Gulf war disease condition and v – siliconosis. Protocol for the practical evaluation of these diseases was suggested. Understanding Shoenfeld Syndrome is crucial for producing vaccines with a safer side effect profile.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":"145 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134913492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening of Antimicrobial Resistance in Bacterial Isolates from Red Sea Coast in Jeddah, Saudi Arabia 沙特阿拉伯吉达红海沿岸细菌耐药性筛选
Journal of Pharmaceutical Research International Pub Date : 2023-09-14 DOI: 10.9734/jpri/2023/v35i247427
Mohannad A. Alsalmi, Hisham N. Altayb
{"title":"Screening of Antimicrobial Resistance in Bacterial Isolates from Red Sea Coast in Jeddah, Saudi Arabia","authors":"Mohannad A. Alsalmi, Hisham N. Altayb","doi":"10.9734/jpri/2023/v35i247427","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i247427","url":null,"abstract":"Objectives: Antibiotic resistance is a major public health problem worldwide. There is little data on the incidence, sources, and importance of antibiotic-resistant bacteria on the Red Sea coast of Jeddah. This study aims to identify drug-resistant microbes found on the Red Sea coast in Jeddah and to screen their resistance profile against different antibiotics.
 Methodology: Forty-eight samples were obtained from different locations on the Red Sea coast in Jeddah. Antimicrobial susceptibility tests were performed against the following antibiotic discs (Oxoid): cefotaxime (CTX) (30g); meropenem (MEM) (10g); gentamicin (CN) (10g) and chloramphenicol (C) (30g).
 Results: The isolates showed resistance to Gentamicin 10 mcg (39.47%; 15/38), Cefotaxime 30 mcg (18.42%; 7/38), Meropenem 10 mcg (0%; 0/38) and Chloramphenicol 30 mcg (5.26%; 2/38).
 Conclusion: From this study there is a high resistance rate to cefotaxime, chloramphenicol and gentamicin 39%. This research has substantiated the existence of a substantial prevalence of resistance to various microbial agents within our environment, specifically within the Red Sea in Jeddah. We propose conducting future studies across diverse geographic regions, utilizing extensive sample sizes, to gain a deeper insight into the potential impact of environmental factors and pollution on the propagation of drug-resistant bacteria. Additionally, the identification of these bacterial strains is essential for understanding their characteristics and devising strategies to combat them effectively, thereby assisting in curtailing their proliferation.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134913189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potentiation of Antibacterial Activity of Ciprofloxacin by Essential Oil of Cymbopogon citratus against Fluoroquinolone-resistant Staphylococcus aureus and Escherichia coli 香茅精油增强环丙沙星对耐氟喹诺酮金黄色葡萄球菌和大肠杆菌的抑菌活性
Journal of Pharmaceutical Research International Pub Date : 2023-09-12 DOI: 10.9734/jpri/2023/v35i247425
Adonu Cyril, Onwusoba Restus, Onyi Patrick, Ali Ibeabuchi, Omeh Romanus
{"title":"Potentiation of Antibacterial Activity of Ciprofloxacin by Essential Oil of Cymbopogon citratus against Fluoroquinolone-resistant Staphylococcus aureus and Escherichia coli","authors":"Adonu Cyril, Onwusoba Restus, Onyi Patrick, Ali Ibeabuchi, Omeh Romanus","doi":"10.9734/jpri/2023/v35i247425","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i247425","url":null,"abstract":"Background: Essential oil (EO) of Cymbopogon citratus has been demonstrated to have antibacterial activities against both Gram negative and Gram positive bacteria. The study was, therefore, conducted to evaluate the effects of combined use of C. citratus and ciprofloxacin against fluoroquinolone-resistant Staphylococcus aureus (FQRSA) and Escherichia coli (FQREC).
 Methods: The antibacterial activity of the essential oil was evaluated by agar dilution method while the combination studies were done using Checker-board agar dilution technique.
 Results: The mean MIC values of EO against the FQRSA and FQREC were 0.043 + 0.01 mg/ml and 0.049 mg/ml respectively. When ciprofloxacin was combined with EO of lemongrass, 53.9, 28.3, 17.8 and 0.0 % of the FQRSA isolates showed indifference, additive, synergistic and antagonistic effects respectively. Similarly, when ciprofloxacin was combined with EO of lemongrass at different ratios, 44, 35.5, 20.6 and 0.0 % of the FQREC isolates showed combined effects of additivity, synergism, indifference and antagonism respectively.
 Conclusions: The results revealed the invitro antibacterial potency of Cymbopogon citratus oil against fluoroquinolone resistant S. aureus and E. coli. More importantly, the study has proved that the combined use of ciprofloxacin and essential oil of lemongrass has increased the sensitivity of both FQRSA and FQREC bacteria.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135827313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual Design of Novel Coumarinyl-Substituted Sulfonamide Inhibitors of Carbonic Anhydrase II as Potential Drugs against Glaucoma 新型香豆素基取代磺胺类碳酸酐酶抑制剂作为青光眼潜在药物的虚拟设计
Journal of Pharmaceutical Research International Pub Date : 2023-09-11 DOI: 10.9734/jpri/2023/v35i247424
Eric Ziki, Ludovic Akonan, Koffi Charles Kouman, Brice Dali, Eugene Megnassan, Rita Kakou-Yao, Abodou Jules Tenon, Vladimir Frecer, Stanislav Miertus
{"title":"Virtual Design of Novel Coumarinyl-Substituted Sulfonamide Inhibitors of Carbonic Anhydrase II as Potential Drugs against Glaucoma","authors":"Eric Ziki, Ludovic Akonan, Koffi Charles Kouman, Brice Dali, Eugene Megnassan, Rita Kakou-Yao, Abodou Jules Tenon, Vladimir Frecer, Stanislav Miertus","doi":"10.9734/jpri/2023/v35i247424","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i247424","url":null,"abstract":"Background: We have carried out virtual design of coumarinyl-substituted sulfonamides (CSAM) analogs as inhibitors of human carbonic anhydrase II (hCA II) endowed with favorable predicted pharmacokinetic profiles and potential therapeutic effects against glaucoma.
 Methods: modifying in situ the x-ray structure of 2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(4-sulfamoyl-phenyl)-acetamide (CSAM0)-hCA II complex (PDB entry 3ML2), permitted 3D models of hCA II-CSAMx complexes preparation for a TS of 14 CSAMs the experimental activities of which are available in the literature (IC50exp). Active bound conformation of the CSAM1-14 assessment led to linear correlation between computed enthalpy of hCA II-CSAMx complexes formation in gas phase (ΔΔHMM) with the IC50exp. Moreover, considering the solvation and ligand loss of entropy upon binding led to a superior QSAR model where a better linear correlation is established between calculated GFE (ΔΔGcom) and IC50exp. The successive 3D-pharmacophore (PH4) built from CSAMs active conformations helped to virtually screen CSAM populating a sulfonamides scaffolds virtual combinatorial library (VCL), focused by Lipinski’s rule-of-five to reach novel CSAMs.
 Results: Enthalpy QSAR model: pIC50exp = -0.068×ΔΔHMM + 7.722, R2 = 0.82; GFE QSAR model: pIC50exp = - 0.061× ΔΔGcom + 7.647, R2 = 0.92 and PH4 model: pIC50exp = 1.095×pIC50pre – 0.680, R2 = 0.87. The VCL of more than 1,500,625 CSAMs was lowered to 865,670 drug likely compounds by the Lipinski’s rule (except the restriction Mw ≤ 500 g/mol). The three-point PH4-based screening identified 81 novel CSAMs with predicted IC50pre reaching 78-times better than CSAM1 potency (IC50exp = 23 nM). Computed pharmacokinetic profile of the new candidates showed enhanced cell membrane permeability and high human oral absorption compared to current anti-glaucoma agents.
 Conclusions: Combination of QSAR models of the CSAMs’ affinity to the hCA II, pharmacophore model, and ADME profile guided to the sulfonamides inhibitors identification and helped to in silico screen VCL sulfonamides scaffold bearing analogs and allowed emerging of novel more potent compounds with predicted IC50 and favorable pharmacokinetic profiles.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135981953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Kasa Kasa Kudineer in Treating Insomnia Patients – A Pilot Study Kasa Kasa Kudineer治疗失眠症的初步研究
Journal of Pharmaceutical Research International Pub Date : 2023-09-08 DOI: 10.9734/jpri/2023/v35i247423
S. R, A. N
{"title":"Effectiveness of Kasa Kasa Kudineer in Treating Insomnia Patients – A Pilot Study","authors":"S. R, A. N","doi":"10.9734/jpri/2023/v35i247423","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i247423","url":null,"abstract":"Introduction: For stepping towards a healthy living, parameters like good food, sound sleep and right mind, all plays major role to attain health and eternity, which were spelled by Siddhars since ancient times. Additionally, Sleep is the best, fruitful meditation for a quality of life. But, getting quality sleep with sufficient period is a matter of concern in the modern civilized world, irrespective of ages, which leads to serious consequences. When you're constantly losing sleep because of insomnia, your brain doesn't cooperate your body, thereby disturbing to perform important tasks. Hence, Insomnia is a significant health problem because of its high prevalence and management challenges. The aim of the study was to evaluate the effectiveness of Siddha medicine Kasa Kasa Kudineer (KKK), in treating insomnia patients, attending OPD at AAGHIM, Chennai. \u0000Study Design: This was a Pilot study with a sample size of 20, with the intervention of Siddha Medicine Kasa Kasa Kudineer, and the outcome was assessed by the Insomnia Severity Index Score. \u0000Place of Study: The study was conducted at Arignar Anna Government Hospital of Indian Medicine and Homeopathy, attached with Government Siddha Medical College (AAGHIM attached with GSMC), Chennai- 106. \u0000Materials and Methods: The study was conducted at the Arignar Anna Govt. Hospital of Indian Medicine (AAGHIM), attached with Govt. Siddha Medical College, Chennai 106, with a sample size of 20. The study protocol and informed consent were reviewed and approved by IEC (with a waiver from IEC). Patients attending the OPD of AAGHIM with complaints of sleep disturbances were chosen for enrollment based on their insomnia severity index score of more than 15. Siddha Medicine Kasa Kasa Kudineer were adminstrated and the observations were made before and after the treatment using the score. \u0000Results: Results were analyzed. Descriptive statistics, Paired t- test were analyzed using SPSS trial version 25, and out of 20 patients, 17 patients shown significant improvement in  their sleep pattern and the total score were also moved to no clinically significant category of Insomnia severity index score. All parameters whose p value is less than 0.05 reject the null hypothesis. Results were encouraging, as it shown considerable improvement by the end of the study. \u0000Conclusion: This study reveals the significant effectiveness of treating Clinically significant insomnia patients, attending OPD at AAGHIM, Chennai with Kasa Kasa Kudineer (KKK), which may ignite a new Siddha medicine for a better quality of life.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43598603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of P-Glycoprotein (P-gp) in Cancer Multidrug Resistance (MDR): Challenges for Inhibiting P-gp in the Context of Overcoming MDR p -糖蛋白(P-gp)在癌症多药耐药(MDR)中的作用:在克服MDR的背景下抑制P-gp的挑战
Journal of Pharmaceutical Research International Pub Date : 2023-08-31 DOI: 10.9734/jpri/2023/v35i237422
W. S. Al-Thubiani
{"title":"The Role of P-Glycoprotein (P-gp) in Cancer Multidrug Resistance (MDR): Challenges for Inhibiting P-gp in the Context of Overcoming MDR","authors":"W. S. Al-Thubiani","doi":"10.9734/jpri/2023/v35i237422","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i237422","url":null,"abstract":"Multidrug resistance (MDR), as is well known, is regarded as the primary factor in cancer therapy failure. A common mechanism of MDR in anticancer drugs is the expression of P-glycoprotein (P-gp), a class of ATP-dependent membrane transport efflux pumps called adenosine triphosphate (ATP)-binding cassette (ABC) transporters. It pumps xenobiotics outside the cell and plays part in typical physiological detoxification and host defense activities. This transporter is distributed in gastrointestinal mucosa epithelial cell surfaces, blood-tissue barriers, hepatic biliary epithelium, proximal tubules of the kidney, and the adrenal cortex. P-gp is known to be responsible for MDR because of its over-expression in malignant cells. It functions as an efflux pump lowering the concentration of drugs intracellularly, thus decreasing the effectiveness of cancer chemotherapy. Although using multiple anticancer medications is a good strategy, Cancerous cells are able to develop MDR. A number of chemically synthesized P-gp inhibitors were investigated to overcome MDR in clinical studies. Additionally, certain natural compounds have been observed to modulate P-gp. Numerous investigations on strategies to modulate MDR have been conducted as a result of the significant impact of chemotherapeutic drug resistance. This review discusses the role of P-gp in cancer MDR and challenges for inhibiting P-gp in the context of overcoming MDR mediated by P-gp. It is concluded that the discovery of selective, safe, and potent inhibitors of P-gp remains necessary.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71204544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Different Doses of Oral Clonidine as Premedication in Attenuating Haemodynamic Response to Pneumoperitoneum in Patients During Laparoscopic Cholecystectomy 不同剂量可乐定口服预用药对腹腔镜胆囊切除术患者气腹血液动力学反应的影响
Journal of Pharmaceutical Research International Pub Date : 2023-08-29 DOI: 10.9734/jpri/2023/v35i237421
Saloni T. Mehta, Shaji Mathew, Suvajit Podder, D. Shetty
{"title":"Efficacy of Different Doses of Oral Clonidine as Premedication in Attenuating Haemodynamic Response to Pneumoperitoneum in Patients During Laparoscopic Cholecystectomy","authors":"Saloni T. Mehta, Shaji Mathew, Suvajit Podder, D. Shetty","doi":"10.9734/jpri/2023/v35i237421","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i237421","url":null,"abstract":"Background: Laparoscopy procedures have gained an increasing demand over the years and rightly so due to its numerous advantages proving it superior to open surgeries. This is therefore important to all the anaesthesiologists to learn the physiological changes during laparoscopic surgery as well how to manipulate and blunt the hemodynamics as well.\u0000Methods: We have taken one such drug, an alpha agonist, oral clonidine and compared its 3 different doses to conclude the most efficacious and safe dosage amongst it.\u0000Results: 100 mcg dose of oral Clonidine is the most safest and most effective amongst the 3 doses of 50, 100 and 150 mcg.\u0000Conclusion: 1) Premedication with oral clonidine is a safe and effective method that provides haemodynamic stability against the neuroendocrine responses due to carboperitoneum in patients undergoing laparoscopic cholecystectomy.\u00002) Escalation of doses from 100 microgram to 150 microgram increases adverse effects and does not enhance efficacy.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42919772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4 AT Delirium Assessment Tool in Hospitalized Non-ICU Patients (≥65 Years): A Systematic Review on Validity and Reliability 住院非ICU患者(≥65岁)的4 AT谵妄评估工具:有效性和可靠性的系统评价
Journal of Pharmaceutical Research International Pub Date : 2023-08-28 DOI: 10.9734/jpri/2023/v35i237420
Mohamed Ali Ahmed Hassabo, Abdulrhman Mohamed Ali Mohamed, Massab Bashir Khaira
{"title":"4 AT Delirium Assessment Tool in Hospitalized Non-ICU Patients (≥65 Years): A Systematic Review on Validity and Reliability","authors":"Mohamed Ali Ahmed Hassabo, Abdulrhman Mohamed Ali Mohamed, Massab Bashir Khaira","doi":"10.9734/jpri/2023/v35i237420","DOIUrl":"https://doi.org/10.9734/jpri/2023/v35i237420","url":null,"abstract":"Background: Delirium is a frequent acute neuropsychiatric illness that affects attention, consciousness, and cognition. \u0000Objectives: The 4AT evaluation tool's validity and reliability in hospitalized non-ICU patients over 65 were assessed in this systematic study. \u0000Method: PRISMA guidelines and the PICO framework were used, and relevant research papers were found utilizing several databases (PubMed, Scopus, Web of Sciences, and ScienceDirect). The Mixed Methods Appraisal Tool was used to evaluate the study's quality. \u0000Results: 257 relevant publications were found, and only ten articles were selected based on inclusion criteria after the screening. Several studies were reported from various regions, including Asia, Europe, Canada, and Australia. Furthermore, studies found varying prevalence levels for 4AT and control groups, with the greatest for the 4AT group being 40.32%. Moreover, most research employed DSM-5 criteria, while some relied on CAM, DSM-4, and Psychiatric examination by qualified clinicians. Meanwhile, the sensitivity varied from 70% to 100%, and the specificity ranged from 71.6% to 99.2%. In contrast, other assessment tools, such as CAM and OBS, also demonstrated sensitivity and specificity. The main advantage was the time to complete the 4AT tool, which required 2-3 minutes, whereas the other tools took 3.6 and 12.46 minutes, respectively. The 4AT tool was a rapid, validated, easy patient assessment tool. In addition, it was found to improve delirium diagnosis. \u0000Conclusion: The tool has been found to have good sensitivity and specificity, and it may be completed quickly by non-specialists.","PeriodicalId":16718,"journal":{"name":"Journal of Pharmaceutical Research International","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45790833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信